• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?

作者信息

Narod Steven, Sopik Victoria

机构信息

Women's College Research Institute, 76 Grenville Street, Toronto, Ontario, Canada.

Women's College Research Institute, 76 Grenville Street, Toronto, Ontario, Canada.

出版信息

Gynecol Oncol. 2017 Feb;144(2):238-240. doi: 10.1016/j.ygyno.2016.11.046. Epub 2016 Dec 22.

DOI:10.1016/j.ygyno.2016.11.046
PMID:28017307
Abstract
摘要

相似文献

1
Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?晚期卵巢癌的新辅助化疗：美国临床肿瘤学会（ASCO）和美国妇科肿瘤学会（SGO）的建议是否合理？
Gynecol Oncol. 2017 Feb;144(2):238-240. doi: 10.1016/j.ygyno.2016.11.046. Epub 2016 Dec 22.
2
The Tip of the Iceberg.冰山一角。
J Clin Oncol. 2017 Mar;35(7):801-802. doi: 10.1200/JCO.2016.70.6747. Epub 2016 Dec 28.
3
Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer.晚期上皮性卵巢癌女性在确定手术方案前进行新辅助化疗。
Taiwan J Obstet Gynecol. 2018 Oct;57(5):623-624. doi: 10.1016/j.tjog.2018.08.001.
4
[Role of neoadjuvant chemotherapy in the advanced ovarian cancer].[新辅助化疗在晚期卵巢癌中的作用]
Lijec Vjesn. 2013 Jan-Feb;135(1-2):21-6.
5
Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer.晚期卵巢癌手术减瘤的合理建议。
Curr Treat Options Oncol. 2016 Jan;17(1):1. doi: 10.1007/s11864-015-0380-2.
6
The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.新辅助化疗在晚期卵巢癌患者管理中的作用：妇科肿瘤学家学会成员的调查结果。
Gynecol Oncol. 2010 Oct;119(1):18-21. doi: 10.1016/j.ygyno.2010.06.021. Epub 2010 Jul 31.
7
Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study.新辅助化疗应用于晚期卵巢癌对全因死亡率的影响：一项准实验研究。
BMJ. 2018 Jan 3;360:j5463. doi: 10.1136/bmj.j5463.
8
Neoadjuvant Chemotherapy or Primary Debulking Surgery for Stage IIIC Ovarian Cancer.IIIC期卵巢癌的新辅助化疗或初次肿瘤细胞减灭术
J Clin Oncol. 2017 Mar;35(7):802-803. doi: 10.1200/JCO.2016.70.7125. Epub 2016 Dec 28.
9
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?晚期卵巢癌的新辅助化疗：需要何种证据才能说服美国妇科肿瘤学家？
Gynecol Oncol. 2010 Oct;119(1):1-2. doi: 10.1016/j.ygyno.2010.08.011.
10
Neoadjuvant chemotherapy for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的新辅助化疗
Clin Adv Hematol Oncol. 2016 Apr;14(4):262-8.

引用本文的文献

1
Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer.预测高级别浆液性卵巢癌患者肿瘤浸润淋巴细胞密度的列线图
Front Oncol. 2021 Feb 25;11:590414. doi: 10.3389/fonc.2021.590414. eCollection 2021.
2
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.评估实体瘤中的肿瘤浸润淋巴细胞：病理学家实用综述及国际免疫肿瘤生物标志物工作组提出的标准化方法建议：第 2 部分：黑色素瘤、胃肠道癌、非小细胞肺癌和间皮瘤、子宫内膜癌和卵巢癌、头颈部鳞状细胞癌、泌尿生殖道癌和脑原发性肿瘤中的 TILs。
Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161.